¿ÀÁ¤È¯(Oh Jung-Hwan) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼º¹Ù¿À·Îº´¿ø ³»°úÇб³½Ç
Abstract
Peptic ulcer disease is one of the most commonly encountered diseases. Despite the decrease of Helicobacter pylori infection, the use of aspirin and non-steroidal anti-inflammatory drugs has increased in recent years. Peptic ulcer bleeding is a common emergency associated with high mortality. As an adjunct to endoscopic treatment, acid suppression with proton pump inhibitors (PPIs) is im-portant in the management of peptic ulcer bleeding. A high dose intravenous PPI is effective in reducing rebleeding and the need for surgery. However, data about non-high dose intravenous PPIs are limited. In addition, novel PPIs are focused in this review, since progress has been made regarding new PPIs.
Å°¿öµå
Peptic ulcer, Peptic ulcer hemorrhage, Proton pump inhibitors, Therapy
KMID :
0931320140140010013
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)